首页> 外文期刊>Head and neck: Journal for the sciences and specialities of the head and neck >Basaloid squamous cell carcinoma of the larynx: Analysis of 145 cases with comparison to conventional squamous cell carcinoma
【24h】

Basaloid squamous cell carcinoma of the larynx: Analysis of 145 cases with comparison to conventional squamous cell carcinoma

机译:喉基底膜鳞状细胞癌:与常规鳞状细胞癌比较145例分析

获取原文
获取原文并翻译 | 示例
           

摘要

Background Basaloid squamous cell carcinoma (BSCC) is a rare subtype squamous cell carcinoma (SCC) that frequently occurs in the larynx. BSCC is generally considered an aggressive SCC variant; however, because of its rarity, most studies are underpowered to detect statistical differences in disease-specific survival (DSS). Methods Using the Surveillance, Epidemiology, and End Results (SEER) database, we compared clinicopathologic data and DSS between patients with laryngeal BSCC and SCC. Results Patients with relative SCC, those with laryngeal BSCC, presented with more advanced local, regional, and distant disease (p <.001). Patients with BSCC had worse DSS, regardless of stage, tumor location within the larynx (glottis/supraglottis; p <.001), or treatment received (p ≤.052). Conclusion Analysis of the largest laryngeal BSCC series to date (n = 145) demonstrates that BSCC carries a worse prognosis than conventional SCC of the larynx.
机译:背景鳞状上皮鳞状细胞癌(BSCC)是一种罕见的亚型鳞状细胞癌(SCC),经常在喉中发生。 BSCC通常被认为是侵略性SCC变体。然而,由于其稀有性,大多数研究不足以检测疾病特异性生存率(DSS)的统计差异。方法使用监测,流行病学和最终结果(SEER)数据库,比较喉BSCC和SCC患者的临床病理数据和DSS。结果相对SCC患者,喉BSCC患者表现出更晚期的局部,区域和远处疾病(p <.001)。 BSCC患者的DSS较差,无论其分期,喉内肿瘤位置(声门/声门上; p <.001)还是接受治疗(p≤.052)。结论对迄今为止最大的喉癌BSCC系列(n = 145)的分析表明,与传统的喉癌SCC相比,BSCC的预后更差。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号